Assembly Bill A962A

Signed By Governor
2013-2014 Legislative Session

Provides that persons with clotting protein deficiencies who are otherwise eligible for certain health insurance programs shall have access to reimbursement for certain treatments

download bill text pdf

Sponsored By

Archive: Last Bill Status - Signed by Governor


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

multi-Sponsors

2013-A962 - Details

See Senate Version of this Bill:
S2186
Law Section:
Public Health Law
Laws Affected:
Amd §2510, Pub Health L
Versions Introduced in 2011-2012 Legislative Session:
A6039, S3865

2013-A962 - Summary

Provides that persons with hemophilia and other clotting protein deficiencies who are otherwise eligible for the Child Health Plus program shall have access to reimbursement for outpatient blood clotting factor concentrates and other necessary treatments and services.

2013-A962 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                   962

                       2013-2014 Regular Sessions

                          I N  A S S E M B L Y

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by  M. of A. KELLNER, CROUCH, FINCH -- Multi-Sponsored by --
  M. of A. CURRAN, CUSICK, HEVESI, LUPARDO, MARKEY, WALTER -- read  once
  and referred to the Committee on Health

AN  ACT  to  amend the public health law and the social services law, in
  relation to providing that persons with hemophilia and other  clotting
  protein  deficiencies  who are otherwise eligible for the Child Health
  Plus or Family Health Plus programs shall have access to reimbursement
  for outpatient blood clotting factor concentrates and other  necessary
  treatments and services

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.   Legislative findings. Hemophilia  is  a  rare  hereditary
bleeding disorder resulting from a deficiency in blood proteins known as
clotting factors.  Without an adequate supply of clotting factors, indi-
viduals  can experience prolonged bleeding following routine medical and
dental procedures, trauma, and a range  of  physical  activities.  Addi-
tionally,  individuals  with  hemophilia  often  experience  spontaneous
internal bleeding that can cause severe joint damage, chronic pain,  and
even death.
  Prior  to  the  1970s, individuals with hemophilia seldom lived beyond
the age of 30 years. Early treatment consisted of whole blood and plasma
transfusions at hospitals. These treatments were difficult, time consum-
ing and only minimally effective. The advent  of  commercially  prepared
blood  clotting  factors  in  the  1980s  represented a major advance in
treatment, both in terms of efficacy and convenience. Most  importantly,
these advances allowed for home infusion.
  In addition to hemophilia, there are several other disorders resulting
from  blood  protein  deficiencies. These include Von Willebrand Disease
(VWD), the most common bleeding disorder,  affecting  approximately  two
million  Americans.  Individuals  with  the severest form of VWD rely on

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
              

co-Sponsors

multi-Sponsors

2013-A962A (ACTIVE) - Details

See Senate Version of this Bill:
S2186
Law Section:
Public Health Law
Laws Affected:
Amd §2510, Pub Health L
Versions Introduced in 2011-2012 Legislative Session:
A6039, S3865

2013-A962A (ACTIVE) - Summary

Provides that persons with hemophilia and other clotting protein deficiencies who are otherwise eligible for the Child Health Plus program shall have access to reimbursement for outpatient blood clotting factor concentrates and other necessary treatments and services.

2013-A962A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 962--A

                       2013-2014 Regular Sessions

                          I N  A S S E M B L Y

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by M. of A. KELLNER, CROUCH, FINCH, GOTTFRIED -- Multi-Spon-
  sored by -- M.  of A. CURRAN, CUSICK, HEVESI, LENTOL, LUPARDO, MARKEY,
  MOSLEY, WALTER -- read once and referred to the Committee on Health --
  reported and referred to the Committee on Ways and Means --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN  ACT  to  amend  the public health law, in relation to providing that
  persons with hemophilia and other clotting  protein  deficiencies  who
  are  otherwise  eligible  for the Child Health Plus program shall have
  access to reimbursement for outpatient blood clotting  factor  concen-
  trates and other necessary treatments and services

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.   Legislative findings. Hemophilia  is  a  rare  hereditary
bleeding disorder resulting from a deficiency in blood proteins known as
clotting factors.  Without an adequate supply of clotting factors, indi-
viduals  can experience prolonged bleeding following routine medical and
dental procedures, trauma, and a range  of  physical  activities.  Addi-
tionally,  individuals  with  hemophilia  often  experience  spontaneous
internal bleeding that can cause severe joint damage, chronic pain,  and
even death.
  Prior  to  the  1970s, individuals with hemophilia seldom lived beyond
the age of 30 years. Early treatment consisted of whole blood and plasma
transfusions at hospitals. These treatments were difficult, time consum-
ing and only minimally effective. The advent  of  commercially  prepared
blood  clotting  factors  in  the  1980s  represented a major advance in
treatment, both in terms of efficacy and convenience. Most  importantly,
these advances allowed for home infusion.
  In addition to hemophilia, there are several other disorders resulting
from  blood  protein  deficiencies. These include Von Willebrand Disease

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.